Brief: VolitionRx Limited Q2 Loss Per Share $0.15
Aug 13 (Reuters) - VolitionRx Ltd VNRX.A :
* VOLITIONRX LIMITED ANNOUNCES SECOND QUARTER 2018 FINANCIAL
RESULTS AND BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.15
* Q2 EARNINGS PER SHARE VIEW $-0.14 -- THOMSON REUTERS
I/B/E/S
Source text for Eikon: ID:nPn24JHTya
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems